β-hydroxybutyrate crosses the blood–brain barrier and acts as an endogenous histone deacetylase three (HDAC) inhibitor, which has been shown to exert a protective effect in Alzheimer’s disease progression [17]. The gene discussed is HDAC9; the disease is Alzheimer disease.